Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bevacizumab combined with dose dense chemotherapy
Sponsor: Chap, Linnea I., M.D.
Collaborators: Genentech, Inc.